World Health Organisation has added pre-exposure prophylaxis (PrEP) in its recent update of the  Essential Medicines List to prevent HIV infection.

The updated list also comes with an additional treatment of HIV called dolutegravir for treatment of HIV infection, in response to the most recent evidence showing the medicine’s safety, efficacy, and high barrier to resistance.

The update also includes 30 medicines for adults, 25 for children and specifies new users for nine already listed products. This marks the biggest revision for the health agency.

Pre-Exposures Prophylaxis. WHO has added the drug to its Essential Medicines List

“Safe and effective medicines are an essential part of any health system. Making sure all people can access the medicines they need, when and where they need them, is vital to countries’ progress towards universal health coverage,” said Dr Marie-Paule Kieny, WHO Assistant Director-General for Health Systems and Innovation.

The update aims to make sure antibiotics are available when needed and are prescribed for the right infections to reduce development of drug-resistant bacteria.

PrEP was adopted in the Kenya early this year to protect HIV-negative people from contracting the virus.